Drug: ESTRADIOL TRANSDERMAL SYSTEM Injury: Application site erythema Quarter: 2016Q3
Total Records: 12 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
122683522 | ESTRADIOL TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 0.00 | F | 0 | 20160718 | US |
125665631 | ESTRADIOL TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 54.96 YR | F | 0 | 20160718 | US |
125665691 | ESTRADIOL TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 52.93 YR | F | 0 | 20160718 | US |
125665741 | ESTRADIOL TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 53.05 YR | F | 54 KG | 20160718 | US |
125665781 | ESTRADIOL TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 46.54 YR | F | 0 | 20160718 | US |
125665801 | ESTRADIOL TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 0.00 | F | 0 | 20160718 | US |
125665821 | ESTRADIOL TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 0.00 | F | 0 | 20160718 | US |
125665861 | ESTRADIOL TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 0.00 | F | 0 | 20160718 | US |
125665931 | ESTRADIOL TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 0.00 | F | 0 | 20160718 | US |
125665971 | ESTRADIOL TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 67.94 YR | F | 62 KG | 20160718 | US |
125666011 | ESTRADIOL TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 53.00 YR | F | 79 KG | 20160718 | US |
125666171 | ESTRADIOL TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 0.00 | F | 0 | 20160718 | US |
Total Records: 12 Number of Pages: 1